reputation and crisis management...> charterhouse clinical v richmond pharmacology (2003)...
TRANSCRIPT
Please treat all transactions and clients' names as confidential
Reputation and crisis
management – the legal
dimension
PTMG 91st Conference
Warsaw
Timothy Pinto
2 October 2015
Please treat all transactions and clients' names as confidential
˃ Threats
˃ 3 stages
˃ Defamation law
˃ Pre-publication
˃ Post-publication
˃ Germany and Poland
˃ Social media
Topics
Please treat all transactions and clients' names as confidential
Main sources of threat
Media
Ex-employees
Security breaches/data
loss
Adverse events & product liability
Whistle-
blowers
Directors' & employees'
conduct
Regulatory
Investigations
Social media
Where do the threats to a company's reputation come from?
Please treat all transactions and clients' names as confidential
Pharma specific
> Off-label promotion
> Failure to report negative clinical
trials
> Products causing death/injury
> Failure to report adverse events
> Animal testing
> Patenting life
General
> Security breaches/data loss
> Competition law violation
> Tax avoidance/evasion
> Treating employees badly
> IP infringement
> Paying bribes/corruption
> Environmental damage
> Fraud
> Misconduct by CEO/directors
(sex, drugs, etc)
Possible allegations
Please treat all transactions and clients' names as confidential
1. Early planning
– Identify potential vulnerabilities
– Crisis team/plan, including PR and legal
– Social media policies/confidentiality agreements
2. Pre-publication/broadcast – see below
3. Post-publication/broadcast – see below
3-stages
Please treat all transactions and clients' names as confidential
> Applies to all media (including Twitter)
> Defamatory if statement substantially effects in an adverse manner the
attitude of other people towards claimant
> Not defamatory unless statement caused or likely to cause:
– for a body trading for profit, serious financial loss
– for individuals, serious harm to reputation
Defamatory meaning - general
Please treat all transactions and clients' names as confidential
> Criticism only of goods or services is not defamatory
> Charterhouse Clinical v Richmond Pharmacology (2003)
– Email claimed: there was a question mark over Charterhouse's
provision of effective clinical trial services because most of its
clinical research team had left to join Richmond
– Held, no imputation against company itself. Not defamatory.
Goods and services
Please treat all transactions and clients' names as confidential
> U.S. Judge Easterbrook (1994):
– "…Scientific controversies must be settled by the methods of
science rather than by the methods of litigation.… More papers,
more discussion, better data, and more satisfactory models – not
larger awards of damages – mark the path towards superior
understanding of the world around us."
> British Chiropractic Association v Singh (2010)
– "…The [BCA] claims that their members can help treat children with
…frequent ear infections, asthma and prolonged crying, even
though there is not a jot of evidence…"
– English Court of Appeal:
Singh's criticisms were opinion not fact
Scientific debates should not be resolved by the courts
Scientific speech
Please treat all transactions and clients' names as confidential
> Publisher has burden of proof:
– Substantial truth
– Honest opinion
– Publication on a matter of public
interest
– Fair & accurate report of
proceedings of a scientific or
academic conference
– Peer-reviewed statements in a
scientific or academic journal
Defences
Please treat all transactions and clients' names as confidential
> A newspaper journalist emails a
pharmaceutical company at 3pm on a Friday.
> She says she is going to publish her article on
Sunday. She asks for an interview with a
senior manager and gives a 6pm deadline.
> How to respond?
> What can be achieved?
> Will the English court grant an injunction for
defamation?
> Use of lawyers and/or a PR?
Pre-publication - example
Please treat all transactions and clients' names as confidential
> What can be achieved?
– Right of reply
– Take down (online only)
– Amend article (online only)
– Clarification
– Apology
– Undertaking not to repeat the
allegation or similar allegations
– Damages and/or costs
> How to achieve it?
> Press and broadcast regulation
Post-publication/post-broadcast
Please treat all transactions and clients' names as confidential
> Civil Code protects against damage (including to reputation)
– Individuals rely on personality rights
– Companies rely on property rights
> Defences of truth (with exceptions) and public interest/good faith
> Obligatory right of reply
> Ex parte preliminary injunction possible shortly after publication
> Criminal defamation exists but rarely used in press context
German media law
Please treat all transactions and clients' names as confidential
> Personal rights protected under Civil Code (individuals and companies)
– See Stankiewicz v Poland - European Court of Human Rights
(October 2014)
> Obligation to respond to media queries
> Criminal liability exists for discrediting a person/business
Polish media law
Please treat all transactions and clients' names as confidential
> Intermediaries (e.g. websites and ISPs)
– Potential liability?
– Notice and take down?
> Discovering the identity of anonymous users
Social media
Please treat all transactions and clients' names as confidential
Europe > Middle East > Asia www.taylorwessing.com
© Taylor Wessing LLP 2013
This publication is intended for general public guidance and to highlight issues, it is not intended to apply to specific circumstances or to constitute legal advice. Taylor Wessing's international offices operate as one firm but are established as district legal entities. For further information about our offices and
the regulatory regimes that apply to them, please refer to: www.taylorwessing.com/regulatory.html
Europe > Middle East > Asia www.taylorwessing.com
© Taylor Wessing LLP 2014
This publication is intended for general public guidance and to highlight issues, it is not intended to apply to specific circumstances or to constitute legal advice. Taylor Wessing's international offices operate as one firm but are established as district legal entities. For further information about our offices and
the regulatory regimes that apply to them, please refer to: www.taylorwessing.com/regulatory.html
Any questions?
+44 20 7300 4287
Please treat all transactions and clients' names as confidential
Over 1,200
lawyers